Effect of Pyridorin in Patients With Diabetic Nephropathy
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the safety and tolerability of Pyridorin
(pyridoxamine dihydrochloride) 50 mg given orally twice daily in patients with diabetic
kidney disease.